[1] Ahmad N, Feyes DK, Nieminen AL, et a1. Green tea constituent epigallo-catechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells[J]. JNatl Cancer Inst, 1997, 89(24):1881-1886. [2] Aldini G, Yeum KJ, Carini M, et al. (-)-Epigallocatechin-3-gallate prevents oxidative damage in both the aqueous and lipid compartments of human plasma[J]. Biochem Biophys Res Commun, 2003, 302(2):409-414. [3] Fujimura Y, Umeda D, yano S, et al. The 67 kDa laminin receptor as a primary determinant of anti-allergic effects of O-methylated EGCG[J]. Biochem Biophys Res Commun, 2007,364 (1): 79-85. [4] Fujimura Y, Umeda D, Yamada K, et al. The impact of the 67 kDa laminin receptor on both cell-surface binding and anti-allergic action of tea catechins[J]. Arch Biochem Biophys, 2008, 476(2): 133-138. [5] Navarro RE, Santacruz H, Inoue M. Complexation of epigallocatechin gallate (a green tea extract, egcg) with Mn2+: nuclear spin relaxation by the paramagnetic ion[J]. J Inorg Biochem, 2005, 99(2):584-588. [6] JBabich H, Krupka ME, Nissim HA, et al. Differential in vitro cytotoxicity of (-)-epicatechin gallate (ECG) to cancer and normal cells from the human oral cavity[J]. Toxicol In Vitro, 2005(19),19(2):231-242. [7] 陈丽莉, 苏俭生. EGCG对舌鳞癌细胞CAL-27的EGFR、67LR及VEGF表达的影响[J]. 口腔颌面外科杂志.2012, 22(4): 238-241. [8] Lim YC, Cha YY. Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex [J]. J Surg Oncol, 2011, 104(7):776-780. [9] Farooqi AA, Bhatti S, Rana A, et al. Shattering the underpinnings of neoplastic architecture in LNCap: synergistic potential of nutraceuticals in dampening PDGFR/EGFR signaling and cellular proliferation[J]. J Exp Ther Oncol, 2011, 9(3):201-206. [10] Olayioye MA, Neve RM, Lane HA, et al. The ErbB signaling network: receptor heterodimerization in development and cancer [J]. EMBOJ, 2000, 19(13): 3159-3167. |